HSBC Holdings
ADPT icon

HSBC Holdings’s Adaptive Biotechnologies ADPT Stock Holding History

HSBC Holdings’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,797
Closed -$160K – 2912
2025
Q3 		$160K Buy
+10,797
New +$132K ﹤0.01% 2531
2025
Q2 		– Sell
-34,571
Closed -$256K – 3008
2025
Q1 		$256K Sell
34,571
-12,705
-27% -$97.6K ﹤0.01% 2475
2024
Q4 		$289K Buy
47,276
+11,165
+31% +$61.6K ﹤0.01% 2514
2024
Q3 		$187K Buy
36,111
+3,861
+12% +$16.8K ﹤0.01% 2642
2024
Q2 		$114K Sell
32,250
-1,566
-5% -$4.97K ﹤0.01% 2709
2024
Q1 		$109K Sell
33,816
-1,928
-5% -$7.46K ﹤0.01% 2829
2023
Q4 		$175K Sell
35,744
-1,295
-3% -$5.91K ﹤0.01% 2506
2023
Q3 		$201K Buy
37,039
+11,817
+47% +$78.1K ﹤0.01% 2422
2023
Q2 		$170K Sell
25,222
-22,605
-47% -$168K ﹤0.01% 2359
2023
Q1 		$421K Buy
47,827
+240
+0.5% +$2.12K ﹤0.01% 2096
2022
Q4 		$353K Sell
47,587
-2,510
-5% -$19.5K ﹤0.01% 2449
2022
Q3 		$366K Buy
50,097
+4,822
+11% +$45.4K ﹤0.01% 2319
2022
Q2 		$358K Buy
45,275
+15,919
+54% +$140K ﹤0.01% 2531
2022
Q1 		$411K Buy
+29,356
New +$462K ﹤0.01% 2550
2021
Q3 		– Sell
-12,290
Closed -$501K – 2964
2021
Q2 		$501K Buy
12,290
+6,860
+126% +$267K ﹤0.01% 2173
2021
Q1 		$219K Sell
5,430
-985
-15% -$53.3K ﹤0.01% 2500
2020
Q4 		$379K Sell
6,415
-1,599
-20% -$82.5K ﹤0.01% 2392
2020
Q3 		$388K Buy
+8,014
New +$337K ﹤0.01% 2098

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HSBC Holdings's ADPT Position: Q4 2025 in Review

HSBC Holdings sold out of Adaptive Biotechnologies (ADPT) in Q4 2025, closing a stake of 10,797 shares — an estimated $160K sold.

HSBC Holdings first reported a position in ADPT in Q3 2020 and held it in 18 quarters. The position peaked at $501K in Q2 2021. 283 funds tracked by Wall St. Rank hold ADPT as of Q4 2025.

  • HSBC Holdings reported no remaining Adaptive Biotechnologies position as of Q4 2025 after selling out during the quarter.
  • HSBC Holdings sold 10,797 Adaptive Biotechnologies shares in Q4 2025, an estimated $160K.
  • HSBC Holdings first reported a position in Adaptive Biotechnologies in Q3 2020 and held it in 18 quarters.
  • HSBC Holdings's Adaptive Biotechnologies position peaked at $501K in Q2 2021.
  • 283 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2025.

Based on HSBC Holdings's 13F filing for Q4 2025, filed 6 Mar 2026.